167 related articles for article (PubMed ID: 30790420)
1. The rise of Clostridioides difficile infections and fall of associated mortality in hospitalized advanced cirrhotics.
Rosenblatt R; Mehta A; Cohen-Mekelburg S; Shen N; Snell D; Lucero C; Jesudian A; Fortune B; Crawford CV; Kumar S
Liver Int; 2019 Jul; 39(7):1263-1270. PubMed ID: 30790420
[TBL] [Abstract][Full Text] [Related]
2. Early Readmission Predicts Increased Mortality in Cirrhosis Patients After Clostridium difficile Infection.
Kruger AJ; Durkin C; Mumtaz K; Hinton A; Krishna SG
J Clin Gastroenterol; 2019 Sep; 53(8):e322-e327. PubMed ID: 30045168
[TBL] [Abstract][Full Text] [Related]
3. Acute kidney injury impact on inpatient mortality in Clostridium difficile infection: A national propensity-matched study.
Charilaou P; Devani K; John F; Kanna S; Ahlawat S; Young M; Khanna S; Reddy C
J Gastroenterol Hepatol; 2018 Jun; 33(6):1227-1233. PubMed ID: 29205514
[TBL] [Abstract][Full Text] [Related]
4. Predictors of Mortality in Cirrhosis Inpatients With Clostridium difficile Infection.
Smith EZ; Northup PG; Argo CK
J Clin Gastroenterol; 2018 Sep; 52(8):747-751. PubMed ID: 28644310
[TBL] [Abstract][Full Text] [Related]
5. Clostridium difficile Infection in Hospitalized Cirrhotic Patients with Hepatic Encephalopathy.
Stoica OC; Stanciu C; Cojocariu C; Miftode E; Boiculese L; Trifan A; Girleanu I
J Gastrointestin Liver Dis; 2015 Dec; 24(4):423-8. PubMed ID: 26697567
[TBL] [Abstract][Full Text] [Related]
6. Clostridium difficile is associated with poor outcomes in patients with cirrhosis: A national and tertiary center perspective.
Bajaj JS; Ananthakrishnan AN; Hafeezullah M; Zadvornova Y; Dye A; McGinley EL; Saeian K; Heuman D; Sanyal AJ; Hoffmann RG
Am J Gastroenterol; 2010 Jan; 105(1):106-13. PubMed ID: 19844204
[TBL] [Abstract][Full Text] [Related]
7. Changing epidemiology and outcomes of acute kidney injury in hospitalized patients with cirrhosis - a US population-based study.
Desai AP; Knapp SM; Orman ES; Ghabril MS; Nephew LD; Anderson M; Ginès P; Chalasani NP; Patidar KR
J Hepatol; 2020 Nov; 73(5):1092-1099. PubMed ID: 32387698
[TBL] [Abstract][Full Text] [Related]
8. Clostridium difficile infection in patients hospitalized with type 2 diabetes mellitus and its impact on morbidity, mortality, and the costs of inpatient care.
Olanipekun TO; Salemi JL; Mejia de Grubb MC; Gonzalez SJ; Zoorob RJ
Diabetes Res Clin Pract; 2016 Jun; 116():68-79. PubMed ID: 27321318
[TBL] [Abstract][Full Text] [Related]
9. Portal vein thrombosis prevalence and associated mortality in cirrhosis in a nationally representative inpatient cohort.
Cool J; Rosenblatt R; Kumar S; Lucero C; Fortune B; Crawford C; Jesudian A
J Gastroenterol Hepatol; 2019 Jun; 34(6):1088-1092. PubMed ID: 30307066
[TBL] [Abstract][Full Text] [Related]
10. The impact of Clostridioides difficile infection on outcomes among kidney transplant recipients.
Iqbal H; Patel J; Singh I; Kohli I; Thind N; Dhiman M; Sohal A; Yang J
Am J Infect Control; 2024 Jul; 52(7):795-800. PubMed ID: 38395312
[TBL] [Abstract][Full Text] [Related]
11. Acute kidney injury is an independent marker of severity in Clostridium difficile infection: a nationwide survey.
Khanna S; Keddis MT; Noheria A; Baddour LM; Pardi DS
J Clin Gastroenterol; 2013 Jul; 47(6):481-4. PubMed ID: 23059411
[TBL] [Abstract][Full Text] [Related]
12. Cannabis use and risk of Clostridioides difficile infection: Analysis of 59,824 hospitalizations.
Adejumo AC; Bukong TN
Anaerobe; 2020 Feb; 61():102095. PubMed ID: 31493498
[TBL] [Abstract][Full Text] [Related]
13. Hospitalized Patients with Heart Failure and Common Bacterial Infections: A Nationwide Analysis of Concomitant Clostridium Difficile Infection Rates and In-Hospital Mortality.
Mamic P; Heidenreich PA; Hedlin H; Tennakoon L; Staudenmayer KL
J Card Fail; 2016 Nov; 22(11):891-900. PubMed ID: 27317844
[TBL] [Abstract][Full Text] [Related]
14. Trend, Risk Factors, and Costs of Clostridium difficile Infections in Vascular Surgery.
Egorova NN; Siracuse JJ; McKinsey JF; Nowygrod R
Ann Vasc Surg; 2015; 29(4):792-800. PubMed ID: 25595110
[TBL] [Abstract][Full Text] [Related]
15. Chronic Rifaximin Use in Cirrhotic Patients Is Associated with Decreased Rate of C. difficile Infection.
Feuerstadt P; Hong SJ; Brandt LJ
Dig Dis Sci; 2020 Feb; 65(2):632-638. PubMed ID: 31440997
[TBL] [Abstract][Full Text] [Related]
16. Clostridium difficile associated risk of death score (CARDS): a novel severity score to predict mortality among hospitalised patients with C. difficile infection.
Kassam Z; Cribb Fabersunne C; Smith MB; Alm EJ; Kaplan GG; Nguyen GC; Ananthakrishnan AN
Aliment Pharmacol Ther; 2016 Mar; 43(6):725-33. PubMed ID: 26849527
[TBL] [Abstract][Full Text] [Related]
17. The burden of Clostridioides difficile on COVID-19 hospitalizations in the USA.
Sohal A; Chaudhry H; Singla P; Sharma R; Kohli I; Dukovic D; Prajapati D
J Gastroenterol Hepatol; 2023 Apr; 38(4):590-597. PubMed ID: 36662626
[TBL] [Abstract][Full Text] [Related]
18. Trends in
Park SO; Yeo I
Ann Med; 2022 Dec; 54(1):1851-1858. PubMed ID: 35786103
[TBL] [Abstract][Full Text] [Related]
19. Impact of Clostridium difficile infection among pneumonia and urinary tract infection hospitalizations: an analysis of the Nationwide Inpatient Sample.
Becerra MB; Becerra BJ; Banta JE; Safdar N
BMC Infect Dis; 2015 Jul; 15():254. PubMed ID: 26126606
[TBL] [Abstract][Full Text] [Related]
20. The significance of acute kidney injury in Clostridioides difficile infection.
Avni T; Hammud H; Itzhaki O; Gafter-Gvili A; Rozen-Zvi B; Ben-Zvi H; Bishara J; Atamna A
Int J Clin Pract; 2021 Mar; 75(3):e13785. PubMed ID: 33098699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
